Sleeve Gastrectomy is a restrictive bariatric surgery. During this procedure,
the surgeon creates a small, sleeve-shaped stomach. It is larger than the stomach
pouch created during Roux-en-Y bypass—and is about the size of a banana.
What Are the Benefits?
Sleeve Gastrectomy is typically considered as a treatment
option for bariatric surgery patients with a BMI of
60 or higher. It is often performed as the first procedure
in a two-part treatment. The second part of the treatment
can be gastric bypass.
Sleeve Gastrectomy is also an alternative for patients
suffering from morbid obesity whose health risks are
too complicated for traditional surgical weight loss
methods.1
Important Statistics
Typically
patients lose between 33% and 83% of their excess weight
12 to 24 months after sleeve gastrectomy 2
Resolution
of obesity-related, co-morbid conditions (such as type
2 diabetes, hypertension, high cholesterol, and obstructive
sleep apnea) occurred within 12 to 24 months after
sleeve gastrectomy 2
Sleeve
gastrectomy patients experienced resolution rates for
co-morbid conditions that were similar to resolution
rates for other restrictive procedures such as gastric
banding2
Resolved
type 2 diabetes in 47% to 100% of patients in four
studies 1,2,3,4
Resolved hypertension in 15% to 93%
of patients in four studies1,2,3,4
Resolved high cholesterol in 45% to
73% of patients in two studies1,2,3,4
Resolved
obstructive sleep apnea in 56% to 100% of patients
in three studies1,2,3,4
What Are the Risks, Complications, and Side Effects?
Additional risks and complications associated with Sleeve
Gastrectomy include:
Dehiscence (separation of tissue that
was stitched or stapled together)
Leaks from staple lines Ulcers Dyspepsia Esophageal dysmotility Fistula
REFERENCES
Cottam D, Qureshi FG, Mattar SG, et
al. Laparoscopic Sleeve Gastrectomy as an Initial Weight-Loss
Procedure for High-Risk Patients with Morbid Obesity.
Surg Endosc 2006;20(6):859-63.
Moon Han S, Kim WW, Oh JH. Results
of laparoscopic sleeve gastrectomy (LSG) at 1 year
in morbidly obese Korean patients. Obes Surg 2005;15(10):
1469-75.
Silecchia
G, Boru C, Pecchia A, et al. Effectiveness of laparoscopic
sleeve gastrectomy....on co-morbidities in super-obese
high risk patients. Obes Surg 2006;16(9):1138-44.
This information was provided
by Ethicon Endo-Surgery, a Johnson & Johnson Company.